Learn More
Medchemexpress LLC 4-acetamido-N-(tert-butyl)benzamide | 183619-38-7 | 99.8% | 234.29 | C13H18N2O2 | 10 MG

Supplier: Medchemexpress LLC HY10037610MG
CPI-1189 is a small-molecule TNF-α release inhibitor used in preclinical research to investigate inflammatory and neuroprotective mechanisms. It has been reported to inhibit p38 phosphorylation and reduce apoptosis in cellular models, making it useful for studies of neurodegeneration, HIV-related neuronal injury, and oxidative stress.
- Orally active TNF-α release inhibitor suitable for cell-based assays.
- Modulates p38 signaling to reduce inflammation-related apoptosis.
- High chemical purity for reproducible experimental results.
- Available in small-scale quantities for research applications.
- Supplied with datasheet listing CAS, molecular weight, and structural identifiers.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.